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Late-Stage Lithiation-Borylation Methodology** 
Catherine J. Fletcher,a Katherine M. P. Wheelhouseb and Varinder K. Aggarwala* 
 
Giganin 1a1 (Figure 1) is a member of the annonaceous acetogenins, 
a class of compounds characterized by a long aliphatic chain 
punctuated by oxygen functionalities and bearing a terminal methyl-
substituted α,β-unsaturated γ-lactone. They exhibit a broad range of 
important biological activities2 but in particular are highly active 
anti-cancer agents. These compounds are potent inhibitors of 
adenosine triphosphate (ATP) production and consequently deprive 
the cell of energy leading to cell death.3 As cancer cells have a high 
energy demand due to rapid multiplication, this action renders the 
annonaceous acetogenins selective inhibitors of cancer cells. Of 
particular interest is that the annonaceous acetogenins show 
potential for the treatment of multi-drug resistant cancer cells as 
these have an even higher requirement for ATP than the parental 
wild-type. 4  Giganin in particular exhibits good cytotoxicity to 
human lung carcinoma, human breast carcinoma, and human colon 
adenocarcinoma in preliminary tests, 5  making it an especially 
important target for total synthesis. 
Several members of the annonaceous acetogenins have 
previously been synthesised 6  (of particular relevance are the 
syntheses of annonacin, 7 , pyranicin 8  and pyragonicin8c, 9 ), but 
giganin itself has not. This class of molecules is challenging to 
synthesise due to the multiple and remote stereogenic centers 
present along the carbon chain (which have been identified as 4R, 
10R, 17R, 18R and 34S10). A common strategy towards this family 
of molecules has been to first add a functional group (an alkene) 
somewhere between the C4 and C10 hydroxyls and then to use it to 
aid disconnection.6 However, this is wasteful as the functionality has 
to be introduced and then removed at the end. An alternative 
approach would be to disconnect the molecule directly at a 
secondary alcohol as this would not only enable C-C bond formation 
but also potentially control stereochemistry in the process. In this 
paper we report the application of our lithiation-borylation 
methodology to a highly convergent and stereoselective synthesis of 
giganin and demonstrate facile access to other stereoisomers. 
 
Figure 1. Annonaceous acetogenins. 
Recently, we reported the synthesis of enantioenriched 
secondary alcohols using a lithiation-borylation reaction between an 
α-lithiated carbamate and a borane or boronic ester.11 The method 
involved the reaction of an α-lithiated carbamate, generated by 
stereoselective deprotonation in the presence of (−)-sparteine,12 with 
a borane or boronic ester thus forming a boron-ate complex with 
retention of stereochemistry. The boron-ate complex then underwent 
a 1,2-metallate rearrangement with migration of the R group and 
expulsion of the carbamate leaving group, resulting in a secondary 
boronic ester.13,14 Oxidation led to secondary alcohols in very high 
enantiomeric ratios (Scheme 1). Exchanging the diamine ligand for 
(+)-sparteine surrogate15 enables access to the opposite enantiomer 
of secondary alcohol from the same starting materials. The 
methodology is particularly good for generating secondary alcohols 
flanked by similar side chains, as present in giganin, which are 
difficult to synthesise by other methods (e.g. stereoselective 
reduction). 
 
Scheme 1. Lithiation-borylation methodology for the formation of 
secondary alcohols. 
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We chose the C10 hydroxyl stereogenic center as a focal point 
for disconnection, in order to achieve high convergence in the 
synthetic route. Making this disconnection lead to the left hand 
fragment, carbamate 6 and the right-hand fragment, boronic ester 7. 
The butenolide could not be used in tact as the stereocenter at C34 
was known to be very sensitive to mild base,16 and so we planned to 
liberate it at the end by oxidation/elimination. We also believed that 
the steric bulk provided by the adjacent quaternary stereocentre in 7 
might protect the lactone from nucleophilic attack as it has been 
shown that organolithiums can be selective for addition to hindered 
pinacol boronic esters over hindered tert-butyl esters. 17  The left 
hand fragment carbamate 6 could be prepared by a Wittig 
olefination of aldehyde 818 with the phosphonium ylide of 9 which 
itself could be derived from lactone 10.19 Boronic ester 7 could be 
prepared by alkylation of lactone 11 with iodide 12 followed by a 
regioselective hydroboration of the terminal alkene. 
 
Scheme 2. Retrosynthesis of (+)-giganin. 
Preparation of carbamate 6 began with the synthesis of lactone 
10.19 Reaction of tetradecyl magnesium bromide with acrolein gave 
allylic alcohol 13 which was subjected to a Johnson-Claisen 
rearrangement to give γ,δ-unsaturated ester 14. Subsequent 
Sharpless dihydroxylation gave the syn vicinal diol with >99:1 e.r.20 
which spontaneously cyclized to give lactone 10. Our modified 
synthesis of lactone 10 was more readily amenable to scale-up.19 
LiAlH4 reduction followed by acetal formation gave acetonide 15 
which was converted via the iodide into the phosphonium salt 9. 
The aldehyde coupling partner 818 was prepared in two steps 
from 1,4-butanediol by firstly, selective monocarbamoylation, 
followed by mild oxidation 21  of the remaining alcohol to the 
aldehyde. Treatment of phosphonium salt 9 with NaHMDS at 
−78 °C followed by aldehyde 8 and subsequent warming to room 
temperature led to carbamate 6 as a single diastereoisomer. 
 
 
Scheme 3. Synthesis of left hand fragment carbamate 6 a)i) Mg, Et2O, 
ii) acrolein, 71%; b) CH3C(OEt3), EtCOOH, PhH, 84%; c) ADmix β, 
CH3SO2NH2, tBuOH/H2O, 73%; d) LiAlH4, Et2O; e) C(CH3)2(OMe)2, 
TsOH, PhH 75% (over 2 steps); f) PPh3, imidazole, I2; g) PPh3, MeCN, 
reflux 18 h, 84% (over 2 steps); h) NaH, CbCl (0.33 eq), THF; i) 
TCCA, TEMPO, CH2Cl2 82% (over 2 steps); j) 9, THF, NaHMDS, 
−78 °C, then 8, −78 °C to rt, 18 h, 79%. 
 
Scheme 4. Synthesis of boronic esters 7 and lactone 11. a) i) Mg, 
Et2O, ii) (R)-epichlorohydrin, CuI 87%; b) NaI, acetone 89%; c) TBSCl, 
imidazole, CH2Cl2, rt, 40 h, 94%; d) 2 eq. 11, 2 eq. LDA, 0 °C, 30 min, 
then 12, rt, 60 h, 73%; e) R2=pinacol: [Ir(COD)Cl]2, dppe, (pin)BH 
CH2Cl2, 79%; R2=neopentyl glycol: [Ir(COD)Cl]2, dppb, CH2Cl2 
(cat)BH; neopentyl glycol, 59%; R2=9BBN: 9BBN, THF, rt, 2 h, (After 
oxidation at rt for 2 h with NaOAc/H2O2) 98%; f) i) LDA, 
PhSCH2COOH, ii) TsOH, PhH 84% (over 2 steps). 
 
Scheme 5. Model systems. a) 7a, b or c, 0.5 h, −78 °C, warm to rt; iii) 
NaOAc/H2O2; b) 19, 0.5 h, −78 °C, warm to rt; iii) NaOH/H2O2. 
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The right hand fragment, boronic ester 7a, was synthesised as 
outlined in Scheme 4. Reaction of but-3-enyl magnesium bromide 
with (R)-epichlorohydrin, followed by a Finkelstein reaction and 
TBS protection led to alkene 12. Alkylation of alkene 12 with 
lactone 11 [synthesised by reaction of the dianion of 
(phenylthio)acetic acid with (S)-propylene oxide followed by 
cyclization with TsOH22] followed by regioselective hydroboration23 
with [Ir(COD)Cl]2, dppe and pinacol borane gave the pinacol 
boronic ester 7a. 
With all of the fragments in hand, our attention turned to the 
lithiation-borylation key step, but model studies were conducted 
first. Initially, boronic ester 7a was reacted with 1-lithio-1-
phenylethyldiisopropyl carbamate 16 but this only gave 25% yield 
of the desired product 17. Evidently, attack of the lithiated 
carbamate at the lactone carbonyl competed with reaction at the 
boronic ester. To try to enhance the chemoselectivity, alternative 
boron derivatives were also tested including the less hindered 
neopentyl glycol ester 7b and the more electrophilic 9-BBN 
derivative but no significant improvements resulted (Scheme 6). We 
therefore sought to simplify the boronic ester fragment by removing 
the lactone moiety. Boronic ester 19 was prepared by an analogous 
regioselective hydroboration of iodoalkene 12 with pinacol borane. 
Pleasingly, this reacted cleanly with lithiated 1-
phenylethyldiisopropyl carbamate to give the desired product 18 in 
73% yield. The excellent chemoselectivity for addition of the 
lithiated carbamate to the boronic ester over the iodide of 19 is also 
noteworthy. 
Having established a successful lithiation-borylation reaction in 
our model system we moved to the real system. However, the 
attempted coupling of boronic ester 19 with the required carbamate 
6, initially gave only low yields (~25%) and significant quantities of 
starting materials were recovered. Upon close examination, it was 
found that the reaction mixture had formed a gel at low temperature, 
presumably due to the unusual physical properties of the long alkyl 
chain of the carbamate. Fortunately, the carbamate was sufficiently 
soluble in tertbutylmethyl ether at −78 °C and subsequent lithiation-
borylation gave intermediate 20a in 55% yield (81% brsm24) and 
98:2 d.r. 25  By using the diamine (−)-sparteine in place of (+)-
sparteine surrogate, intermediate 20b with the opposite 
configuration at the C10 carbon was obtained in 71% yield (94% 
brsm) and 98:2 d.r. Alcohol 20a had the required stereochemistry to 
complete the synthesis of (+)-giganin 1a. The alcohol at C10 in both 
diastereomers of 20 was protected as the TBS ether followed by 
alkylation with lactone 11 to give 22a and 22b each as a ~5:1 
inconsequential mixture of epimers at the C2 position and in 66% 
and 68% yields respectively. Selective oxidation of the sulfide to the 
sulfoxide was achieved by treatment with 1 equivalent of mCPBA 
and elimination of the sulfoxide to give the butenolide occurred 
spontaneously during solvent removal in vacuo to give 23a and 23b 
in 89% and 85% respectively. Finally, deprotection with AcCl in 
MeOH led to natural (+)-giganin 1a and (+)-C10-epi-giganin 1b in 
99% and 93% yields respectively. The synthetic material of (+)-
giganin 1a was identical to the natural product in all respects.1 
Unsurprisingly, the two diastereomers were identical by 1H NMR 
but differences in the 13C NMR were discernible.26 
In summary, we have completed the first synthesis of (+)-
giganin 1a in 13 steps (longest linear sequence) and 7% overall 
yield using the lithiation-borylation reaction. Not only does the 
methodology lead to a convergent synthesis in good overall yield, 
but it also provides complete control over the stereochemistry at the 
C10 secondary alcohol, illustrated by the synthesis of both (+)-
giganin 1a and (+)-C10-epi-giganin 1b with equal ease. The 
stitching together of large complex fragments as part of the end 
game also demonstrates the power of lithiation-borylation 
methodology as a practical tool for synthesis. 
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